Differential Expression of Trypsin in Human Ovarian Carcinomas and Low-Malignant-Potential Tumors
- 28 February 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 68 (2), 162-165
- https://doi.org/10.1006/gyno.1997.4912
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: An immunohistochemical studyHuman Pathology, 1997
- Trypsinogen expression in human ovarian carcinomasInternational Journal of Cancer, 1995
- Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomasHuman Pathology, 1995
- Characterization of Matrix‐degrading Proteinases and Their Inhibitors Secreted by Human Gynecological Carcinoma CellsJapanese Journal of Cancer Research, 1995
- Cancer of the OvaryNew England Journal of Medicine, 1993
- Comparison of Extracellular Matrix-Degrading Activities between 64-kDa and 90-kDa Gelatinases Purified in Inhibitor-Free Forms from Human Schwannoma Cells1The Journal of Biochemistry, 1992
- Ovarian serous borderline tumors with stromal microinvasion: A report of 21 casesHuman Pathology, 1990
- Survey of clinical behavior of patients with borderline epithelial tumors of the ovaryGynecologic Oncology, 1981
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980
- Borderline and malignant mucinous tumors of the ovary.Histologic criteria and clinical behaviorCancer, 1973